JAVMA news
FDA gives conditional approval to canine lymphoma drug
The agency granted the conditional approval through the Minor Use/Minor Species regulatory pathway, which lets companies sell treatments for uncommon…
JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
JAVMA news
FDA conditionally approves drug for treating lymphoma in dogs
The Food and Drug Administration announced Jan. 3 that it has conditionally approved Tanovea-CA1, or rabacfosadine, as the first animal drug to treat…
JAVMA news
Man accused of selling fake cancer cures, preying on grieving dog owners
A drug researcher previously convicted of killing his wife is now accused of selling fraudulent treatments for canine cancer.
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
New listings in the AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
New listings in AVMA Animal Health Studies Database
Information about participation in the studies is available in the database.
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
AVMA Animal Health Studies Database reaches 5 years, 500 listings
This June, the AVMA Animal Health Studies Database is marking the fifth anniversary of its launch. The AAHSD also recently surpassed 500 listings of…